Jikui Shen

Jikui Shen

Johns Hopkins University

H-index: 40

North America-United States

About Jikui Shen

Jikui Shen, With an exceptional h-index of 40 and a recent h-index of 26 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Vascular Biology, Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Suprachoroidal gene transfer with nonviral nanoparticles in large animal eyes

Advanced Functions Embedded in the Second Version of Database, Global Evaluation of SARS-CoV-2/hCoV-19 Sequences 2

Proteosomal degradation impairs transcytosis of AAV vectors from suprachoroidal space to retina

TREATMENT OF EYE DISEASES WITH A TOTALLY HUMAN POST-TRANSLATION MODIFIED ANTI-VEGF FAB

GESS: a database of global evaluation of SARS-CoV-2/hCoV-19 sequences

Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen …

Structure-Guided Molecular Engineering of a Vascular Endothelial Growth Factor Antagonist to Treat Retinal Diseases

Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2

Jikui Shen Information

University

Position

Wilmer Eye Institute

Citations(all)

5058

Citations(since 2020)

1827

Cited By

3961

hIndex(all)

40

hIndex(since 2020)

26

i10Index(all)

59

i10Index(since 2020)

50

Email

University Profile Page

Google Scholar

Jikui Shen Skills & Research Interests

Vascular Biology

Immunology

Top articles of Jikui Shen

Suprachoroidal gene transfer with nonviral nanoparticles in large animal eyes

Science Advances

2020/7/3

Advanced Functions Embedded in the Second Version of Database, Global Evaluation of SARS-CoV-2/hCoV-19 Sequences 2

Frontiers in Medicine

2022/4/11

Proteosomal degradation impairs transcytosis of AAV vectors from suprachoroidal space to retina

Gene therapy

2021/12

TREATMENT OF EYE DISEASES WITH A TOTALLY HUMAN POST-TRANSLATION MODIFIED ANTI-VEGF FAB

2021/9/29

GESS: a database of global evaluation of SARS-CoV-2/hCoV-19 sequences

Nucleic acids research

2021/1/8

Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen …

Cell death & disease

2020/10/22

Structure-Guided Molecular Engineering of a Vascular Endothelial Growth Factor Antagonist to Treat Retinal Diseases

Cellular and molecular bioengineering

2020/10

Angela Zhu
Angela Zhu

H-Index: 5

Jikui Shen
Jikui Shen

H-Index: 27

Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2

Frontiers in microbiology

2020/9/25

TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF Fab

2020/9/3

Transgene expression in RPE and retina after suprachoroidal delivery of AAV vectors

Investigative Ophthalmology & Visual Science

2020/6/10

Kun Ding
Kun Ding

H-Index: 11

Jikui Shen
Jikui Shen

H-Index: 27

Inhibiting NF-κB signaling activation reduces retinal neovascularization by promoting a polarization shift in macrophages

Investigative Ophthalmology & Visual Science

2020/6/3

Sustained delivery of acriflavine from the suprachoroidal space provides long term suppression of choroidal neovascularization

Biomaterials

2020/6/1

Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles

Nature communications

2020/2/4

Distinct genetic spectrums and evolution patterns of SARS-CoV-2

Health Informatics

2020/1/1

See List of Professors in Jikui Shen University(Johns Hopkins University)

Co-Authors

academic-engine